NYSE:BHC Bausch Health Companies (BHC) Stock Price, News & Analysis $5.99 +0.11 (+1.87%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$5.69▼$6.0450-Day Range$5.81▼$7.6252-Week Range$3.96▼$11.46Volume5.03 million shsAverage Volume3.27 million shsMarket Capitalization$2.16 billionP/E RatioN/ADividend YieldN/APrice Target$9.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Bausch Health Companies alerts: Email Address Bausch Health Companies MarketRank™ Stock AnalysisAnalyst RatingHold2.20 Rating ScoreUpside/Downside63.6% Upside$9.80 Price TargetShort InterestBearish5.11% of Float Sold ShortDividend StrengthN/ASustainability-1.42Upright™ Environmental ScoreNews Sentiment0.23Based on 27 Articles This WeekInsider TradingN/AProj. Earnings Growth16.39%From $3.60 to $4.19 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.17 out of 5 starsMedical Sector181st out of 936 stocksPharmaceutical Preparations Industry76th out of 436 stocks 3.1 Analyst's Opinion Consensus RatingBausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageBausch Health Companies has only been the subject of 3 research reports in the past 90 days.Read more about Bausch Health Companies' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.11% of the float of Bausch Health Companies has been sold short.Short Interest Ratio / Days to CoverBausch Health Companies has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Bausch Health Companies has recently decreased by 0.92%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldBausch Health Companies does not currently pay a dividend.Dividend GrowthBausch Health Companies does not have a long track record of dividend growth. Previous Next 4.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreBausch Health Companies has received a 55.47% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Allergy eye drops", "Anti-diarrheal and intestinal anti-inflammatory medication (A07)", "Laxatives", and "Intraocular lenses" products. See details.Environmental SustainabilityThe Environmental Impact score for Bausch Health Companies is -1.42. Previous Next 2.3 News and Social Media Coverage News SentimentBausch Health Companies has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 27 news articles for Bausch Health Companies this week, compared to 4 articles on an average week.Search Interest30 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 30% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Bausch Health Companies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Bausch Health Companies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.12% of the stock of Bausch Health Companies is held by insiders.Percentage Held by Institutions78.65% of the stock of Bausch Health Companies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bausch Health Companies' insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Bausch Health Companies are expected to grow by 16.39% in the coming year, from $3.60 to $4.19 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Companies is -4.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Companies is -4.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Bausch Health Companies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About Bausch Health Companies Stock (NYSE:BHC)Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Read More BHC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BHC Stock News HeadlinesJuly 27 at 1:12 AM | americanbankingnews.comBausch Health Companies (NYSE:BHC) Stock Price Down 5.5% After Analyst DowngradeJuly 26 at 12:47 PM | theglobeandmail.comClosing Bell: Bausch Health Companies Inc up on Thursday (BHC)July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 26 at 3:00 AM | americanbankingnews.comBausch Health Companies Target of Unusually Large Options Trading (NYSE:BHC)July 24 at 5:56 PM | investopedia.comBausch Health Stock Swings Wildly as it Addresses Report It's Considering BankruptcyJuly 24 at 3:50 PM | investorplace.comBHC Stock Plunges as Bausch Health Appears on the Brink of BankruptcyJuly 24 at 1:07 PM | reuters.comBausch Health denies report of bankruptcy filingJuly 24 at 11:59 AM | finance.yahoo.comNanotechnology in medicine: Who are the leading public companies?July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 24 at 11:59 AM | seekingalpha.comBausch Health plunges on report of potential prepackaged Chapter 11 bankruptcyJuly 24 at 6:15 AM | americanbankingnews.comBausch Health Companies Inc. to Post FY2024 Earnings of $3.59 Per Share, Zacks Research Forecasts (NYSE:BHC)July 20, 2024 | ca.investing.comTSX Stung, Like U.S. BrethrenJuly 19, 2024 | nz.finance.yahoo.comBausch Health Companies Inc. (BVF.F)July 19, 2024 | finanznachrichten.deBausch Health Companies Inc: Bausch Health Welcomes Two New Members to the Executive Leadership TeamJuly 19, 2024 | americanbankingnews.comBausch Health Companies (NYSE:BHC) Upgraded to Buy at StockNews.comMay 15, 2024 | finance.yahoo.comRBC Notes Updates on Bausch Xifaxan Patent Litigation with NorwichMay 13, 2024 | finance.yahoo.comRBC Noes Bausch Health Filing For Rehearing in Appellate CourtMay 7, 2024 | seekingalpha.comWhy Bausch Health Stock Plunged After Posting First Quarter 2024 ResultsSee More Headlines Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNYSE:BHC CUSIPN/A CIK885590 Webwww.bauschhealth.com Phone(514) 744-6792Fax514-744-6272Employees20,270Year FoundedN/APrice Target and Rating Average Stock Price Target$9.80 High Stock Price Target$14.00 Low Stock Price Target$7.00 Potential Upside/Downside+63.6%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.24) Trailing P/E RatioN/A Forward P/E Ratio1.66 P/E GrowthN/ANet Income$-592,000,000.00 Net Margins-5.07% Pretax Margin-3.60% Return on Equity-2,370.91% Return on Assets4.88% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio0.85 Sales & Book Value Annual Sales$8.76 billion Price / Sales0.25 Cash Flow$7.40 per share Price / Cash Flow0.81 Book Value($0.23) per share Price / Book-26.04Miscellaneous Outstanding Shares361,330,000Free Float331,678,000Market Cap$2.16 billion OptionableOptionable Beta0.77 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Thomas J. Appio (Age 62)CEO & Director Comp: $2.74MMr. John S. Barresi (Age 51)Senior VP, Controller, Chief Accounting Officer & Interim CFO Comp: $796.8kMs. Seana Carson (Age 51)Executive VP & General Counsel Comp: $872.65kMr. Mirza DautbegovicSenior VP & COOMr. Josh CoyleSenior Vice President of Sales & SalixMs. Kathleen FitzpatrickSenior VP & Chief HR OfficerDr. Tage Ramakrishna M.D. (Age 50)Chief Medical Officer and President of R&D Mr. Jeff HartnessExecutive VP of Market Access, Commercial Operations, Neurology, Generics & Government AffairsDr. Graham JacksonSenior VP & Chief Quality OfficerMr. Cees HeimanSenior Vice President of Europe & CanadaMore ExecutivesKey CompetitorsSummit TherapeuticsNASDAQ:SMMTRoivant SciencesNASDAQ:ROIVLantheusNASDAQ:LNTHRevolution MedicinesNASDAQ:RVMDElanco Animal HealthNYSE:ELANView All CompetitorsInsiders & InstitutionsSG Americas Securities LLCSold 146,915 shares on 7/12/2024Ownership: 0.569%Thompson Investment Management Inc.Bought 26,692 shares on 7/8/2024Ownership: 0.066%Walleye Trading LLCBought 466,300 shares on 5/17/2024Ownership: 0.000%Rokos Capital Management LLPSold 812,682 shares on 5/17/2024Ownership: 0.187%Jane Street Group LLCSold 75,400 shares on 5/16/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Companies' stock was trading at $8.02 at the start of the year. Since then, BHC shares have decreased by 25.3% and is now trading at $5.99. View the best growth stocks for 2024 here. How were Bausch Health Companies' earnings last quarter? Bausch Health Companies Inc. (NYSE:BHC) released its quarterly earnings results on Thursday, May, 2nd. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.75 by $0.16. The business earned $2.15 billion during the quarter, compared to analysts' expectations of $2.18 billion. Bausch Health Companies had a negative net margin of 5.07% and a negative trailing twelve-month return on equity of 2,370.91%. What is Joseph C. Papa's approval rating as Bausch Health Companies' CEO? 43 employees have rated Bausch Health Companies Chief Executive Officer Joseph C. Papa on Glassdoor.com. Joseph C. Papa has an approval rating of 97% among the company's employees. This puts Joseph C. Papa in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. Who are Bausch Health Companies' major shareholders? Bausch Health Companies' top institutional shareholders include SG Americas Securities LLC (0.57%) and Thompson Investment Management Inc. (0.07%). Insiders that own company stock include Seana Carson, Schutter Richard U De, Robert Spurr, Joseph F Gordon and Steven D Miller. View institutional ownership trends. How do I buy shares of Bausch Health Companies? Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Bausch Health Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Gilead Sciences (GILD), Micron Technology (MU), Constellation Software (CSU), Intact Financial (IFC), NVIDIA (NVDA), Netflix (NFLX) and Alibaba Group (BABA). This page (NYSE:BHC) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
